The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 29, 2023
Filed:
May. 03, 2021
Applicant:
Atea Pharmaceuticals, Inc., Boston, MA (US);
Inventors:
Jean-Pierre Sommadossi, Boston, MA (US);
Adel Moussa, Burlington, MA (US);
Assignee:
Atea Pharmaceuticals, Inc., Boston, MA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7076 (2006.01); A61P 31/14 (2006.01); A61K 9/08 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 31/706 (2006.01); A61K 31/7064 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7076 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 9/08 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2054 (2013.01); A61K 31/706 (2013.01); A61K 31/7064 (2013.01); A61P 31/14 (2018.01);
Abstract
The present invention is the use of purine nucleotide phosphoramidates or pharmaceutically acceptable salts thereof administered in an effective amount for the treatment or prevention of COVID-19, an infection caused by the SARS CoV-2 virus in a host, for example a human, in need thereof.